Tag: Galecto Biotech

Galecto Biotech raises €79m to launch idiopathic pulmonary fibrosis trial

pharmanewsdaily- October 27, 2018

Galecto Biotech, a Denmark-based pharma company focused on developing galectin modulators for the treatment of severe diseases such as idiopathic pulmonary fibrosis and cancer, has ... Read More